Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.
MER Indicator |
MER description |
Target Fiscal Year |
Target |
C2.1.D |
By Age: <15 |
2015 |
641 |
C2.1.D |
By Age: 15+ |
2015 |
7,680 |
C2.1.D |
By Age/Sex: <15 Female |
2015 |
341 |
C2.1.D |
By Age/Sex: <15 Male |
2015 |
300 |
C2.1.D |
By Age/Sex: 15+ Female |
2015 |
5,059 |
C2.1.D |
By Age/Sex: 15+ Male |
2015 |
2,621 |
C2.1.D |
By Sex: Female |
2015 |
5,409 |
C2.1.D |
By Sex: Male |
2015 |
2,912 |
C2.1.D |
Number of HIV-positive individuals receiving a minimum of one clinical service |
2015 |
8,321 |
C2.1.D |
Sum of Age disaggregates |
2015 |
8,321 |
C2.1.D |
Sum of Age/Sex disaggregates |
2015 |
8,321 |
C2.1.D |
Sum of Sex disaggregates |
2015 |
8,321 |
C2.1.D_NGI |
By Age: <15 |
2015 |
661 |
C2.1.D_NGI |
By Age: 15+ |
2015 |
7,918 |
C2.1.D_NGI |
By Age/Sex: <15 Female |
2015 |
352 |
C2.1.D_NGI |
By Age/Sex: <15 Male |
2015 |
309 |
C2.1.D_NGI |
By Age/Sex: 15+ Female |
2015 |
5,216 |
C2.1.D_NGI |
By Age/Sex: 15+ Male |
2015 |
2,702 |
C2.1.D_NGI |
By Sex: Female |
2015 |
5,576 |
C2.1.D_NGI |
By Sex: Male |
2015 |
3,003 |
C2.1.D_NGI |
Number of HIV-positive individuals receiving a minimum of one clinical service |
2015 |
8,579 |
C2.1.D_NGI |
Sum of Age disaggregates |
2015 |
8,579 |
C2.1.D_NGI |
Sum of Age/Sex disaggregates |
2015 |
8,579 |
C2.1.D_NGI |
Sum of Sex disaggregates |
2015 |
8,579 |
C2.4.D |
Number of HIV-positive individuals receiving a minimum of one clinical service |
2015 |
8,321 |
C2.4.D |
Number of HIV-positive patients who were screened for TB in HIV care or treatment setting |
2015 |
7,489 |
CARE_CURR |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female |
2015 |
374 |
CARE_CURR |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male |
2015 |
275 |
CARE_CURR |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female |
2015 |
5,018 |
CARE_CURR |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male |
2015 |
2,655 |
CARE_CURR |
Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load |
2015 |
8,322 |
CARE_CURR |
Sum of Aggregated Age/Sex disaggregates |
2015 |
8,322 |
CARE_NEW |
Aggregated Age/sex: <15 Female |
2015 |
95 |
CARE_NEW |
Aggregated Age/sex: <15 Male |
2015 |
102 |
CARE_NEW |
Aggregated Age/sex: 15+ Female |
2015 |
1,403 |
CARE_NEW |
Aggregated Age/sex: 15+ Male |
2015 |
708 |
CARE_NEW |
Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load |
2015 |
2,308 |
CARE_NEW |
Sum of Aggregated Age/sex disaggregates |
2015 |
2,308 |
FN_SITE |
By site support type: Direct Service Delivery (DSD): Number of PEPFAR-supported sites achieving 90% nutrition assessments that result in accurate categorization of malnutrition |
2015 |
2 |
FN_SITE |
By site support type: Direct Service Delivery (DSD): Total number of PEPFAR-supported sites providing nutrition assessment, counseling and support (NACS) services |
2015 |
2 |
FN_SITE |
By site support type: Technical Assistance-only (TA): Number of PEPFAR-supported sites achieving 90% nutrition assessments that result in accurate categorization of malnutrition |
2015 |
2 |
FN_SITE |
By site support type: Technical Assistance-only (TA): Total number of PEPFAR-supported sites providing nutrition assessment, counseling and support (NACS) services |
2015 |
2 |
FN_SITE |
Number of PEPFAR-supported sites achieving 90% nutrition assessments that result in accurate categorization of malnutrition |
2015 |
3 |
FN_SITE |
Sum of Numerator Support Type disaggregates |
2015 |
4 |
FN_SITE |
Total number of PEPFAR-supported sites providing nutrition assessment, counseling and support (NACS) services |
2015 |
4 |
FN_SITE_den |
Sum of Denominator Support Type disaggregates |
2015 |
4 |
FN_THER |
Aggregated Age: <18 |
2015 |
127 |
FN_THER |
Aggregated Age: 18+ |
2015 |
79 |
FN_THER |
Number of clinically malnourished PLHIV who received therapeutic and/or supplementary food during the reporting period |
2015 |
166 |
FN_THER |
Number of PLHIV who were nutritionally assessed and found to be clinically undernourished |
2015 |
2,763 |
FN_THER |
Sum of Aggregated Age disaggregates |
2015 |
206 |
GEND_GBV |
Age: 10-14 |
2015 |
2,911 |
GEND_GBV |
Age: 15-17 |
2015 |
460 |
GEND_GBV |
Age: 18-24 |
2015 |
392 |
GEND_GBV |
Age: 25+ |
2015 |
3,275 |
GEND_GBV |
Number of people receiving post-GBV care |
2015 |
7,038 |
GEND_GBV |
Sex: Female |
2015 |
4,578 |
GEND_GBV |
Sex: Male |
2015 |
2,460 |
GEND_GBV |
Sum of Age disaggregates |
2015 |
7,038 |
GEND_GBV |
Sum of Sex disaggregates |
2015 |
7,038 |
GEND_NORM |
By Age: 10-14 |
2015 |
2,882 |
GEND_NORM |
By Age: 15-19 |
2015 |
342 |
GEND_NORM |
By Age: 20-24 |
2015 |
291 |
GEND_NORM |
By Age: 25+ |
2015 |
437 |
GEND_NORM |
By Sex: Female |
2015 |
1,933 |
GEND_NORM |
By Sex: Male |
2015 |
2,019 |
GEND_NORM |
Number of people completing an intervention pertaining to gender norms, that meets minimum criteria |
2015 |
3,952 |
GEND_NORM |
Sum of Age disaggregates |
2015 |
3,952 |
GEND_NORM |
Sum of Sex disaggregates |
2015 |
3,952 |
HTS_TST |
Age/sex: 10-14 Female |
2015 |
270 |
HTS_TST |
Age/sex: 10-14 Female |
2015 |
270 |
HTS_TST |
Age/sex: 10-14 Male |
2015 |
221 |
HTS_TST |
Age/sex: 10-14 Male |
2015 |
221 |
HTS_TST |
Age/sex: 15-19 Female |
2015 |
963 |
HTS_TST |
Age/sex: 15-19 Female |
2015 |
963 |
HTS_TST |
Age/sex: 15-19 Male |
2015 |
1,484 |
HTS_TST |
Age/sex: 15-19 Male |
2015 |
1,484 |
HTS_TST |
Age/sex: 20-24 Female |
2015 |
843 |
HTS_TST |
Age/sex: 20-24 Female |
2015 |
843 |
HTS_TST |
Age/sex: 20-24 Male |
2015 |
1,244 |
HTS_TST |
Age/sex: 20-24 Male |
2015 |
1,244 |
HTS_TST |
Age/sex: 25-49 Female |
2015 |
2,207 |
HTS_TST |
Age/sex: 25-49 Female |
2015 |
2,207 |
HTS_TST |
Age/sex: 25-49 Male |
2015 |
3,281 |
HTS_TST |
Age/sex: 25-49 Male |
2015 |
3,281 |
HTS_TST |
Age/sex: 5-9 Female |
2015 |
358 |
HTS_TST |
Age/sex: 5-9 Female |
2015 |
358 |
HTS_TST |
Age/sex: 5-9 Male |
2015 |
293 |
HTS_TST |
Age/sex: 5-9 Male |
2015 |
293 |
HTS_TST |
Age/sex: 50+ Female |
2015 |
70 |
HTS_TST |
Age/sex: 50+ Female |
2015 |
70 |
HTS_TST |
Age/sex: 50+ Male |
2015 |
123 |
HTS_TST |
Age/sex: 50+ Male |
2015 |
123 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female |
2015 |
628 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male |
2015 |
514 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female |
2015 |
4,082 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male |
2015 |
6,133 |
HTS_TST |
Aggregated Age/sex: <15 Female |
2015 |
628 |
HTS_TST |
Aggregated Age/sex: <15 Male |
2015 |
514 |
HTS_TST |
Aggregated Age/sex: 15+ Female |
2015 |
4,082 |
HTS_TST |
Aggregated Age/sex: 15+ Male |
2015 |
6,133 |
HTS_TST |
By Test Result: Negative |
2015 |
9,168 |
HTS_TST |
By Test Result: Negative |
2015 |
9,168 |
HTS_TST |
Number of individuals who received T&C services for HIV and received their test results during the past 12 months |
2015 |
11,357 |
HTS_TST |
Number of individuals who received T&C services for HIV and received their test results during the past 12 months |
2015 |
11,357 |
HTS_TST |
Sum of Age/Sex disaggregates |
2015 |
11,357 |
HTS_TST |
Sum of Age/Sex disaggregates |
2015 |
11,357 |
HTS_TST |
Sum of Aggregated Age/Sex <15 |
2015 |
1,142 |
HTS_TST |
Sum of Aggregated Age/Sex <15 |
2015 |
1,142 |
HTS_TST |
Sum of Aggregated Age/Sex 15+ |
2015 |
10,215 |
HTS_TST |
Sum of Aggregated Age/Sex 15+ |
2015 |
10,215 |
HTS_TST |
Sum of Aggregated Age/Sex disaggregates |
2015 |
11,357 |
HTS_TST |
Sum of Aggregated Age/Sex disaggregates |
2015 |
11,357 |
HTS_TST |
Sum of Test Result disaggregates |
2015 |
11,357 |
HTS_TST |
Sum of Test Result disaggregates |
2015 |
11,357 |
HTS_TST_POS |
By Test Result: Positive |
2015 |
2,189 |
HTS_TST_POS |
By Test Result: Positive |
2015 |
2,189 |
LAB_CAP |
By clinical laboratories |
2015 |
1 |
LAB_CAP |
By site support type: Direct Service Delivery (DSD) |
2015 |
1 |
LAB_CAP |
Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests |
2015 |
1 |
LAB_CAP |
Sum of Site Support Type disaggregates |
2015 |
1 |
OVC_SERV |
Age: <1 |
2015 |
22 |
OVC_SERV |
Age: <1 |
2015 |
414 |
OVC_SERV |
Age: 1-4 |
2015 |
82 |
OVC_SERV |
Age: 1-4 |
2015 |
1,559 |
OVC_SERV |
Age: 10-14 |
2015 |
149 |
OVC_SERV |
Age: 10-14 |
2015 |
2,822 |
OVC_SERV |
Age: 15-17 |
2015 |
96 |
OVC_SERV |
Age: 15-17 |
2015 |
1,816 |
OVC_SERV |
Age: 18+ |
2015 |
26 |
OVC_SERV |
Age: 18+ |
2015 |
493 |
OVC_SERV |
Age: 5-9 |
2015 |
145 |
OVC_SERV |
Age: 5-9 |
2015 |
2,763 |
OVC_SERV |
Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS |
2015 |
519 |
OVC_SERV |
Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS |
2015 |
10,151 |
OVC_SERV |
Sex: Female |
2015 |
284 |
OVC_SERV |
Sex: Female |
2015 |
5,388 |
OVC_SERV |
Sex: Male |
2015 |
236 |
OVC_SERV |
Sex: Male |
2015 |
4,480 |
OVC_SERV |
Sum of Age disaggregates |
2015 |
520 |
OVC_SERV |
Sum of Age disaggregates |
2015 |
9,867 |
OVC_SERV |
Sum of Sex disaggregates |
2015 |
520 |
OVC_SERV |
Sum of Sex disaggregates |
2015 |
9,868 |
PMTCT_ARV |
Life-long ART (including Option B+) |
2015 |
38 |
PMTCT_ARV |
Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) |
2015 |
42 |
PMTCT_ARV |
Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery |
2015 |
38 |
PMTCT_ARV |
Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy |
2015 |
13 |
PMTCT_ARV |
Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy |
2015 |
25 |
PMTCT_ARV |
Sum of New and Current disaggregates |
2015 |
38 |
PMTCT_ARV |
Sum of Regimen Type disaggregates |
2015 |
38 |
PMTCT_ARV_NGI |
Life-long ART (including Option B+) |
2015 |
38 |
PMTCT_ARV_NGI |
Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) |
2015 |
42 |
PMTCT_ARV_NGI |
Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery |
2015 |
38 |
PMTCT_ARV_NGI |
Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy |
2015 |
12 |
PMTCT_ARV_NGI |
Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy |
2015 |
25 |
PMTCT_ARV_NGI |
Sum of New and Current disaggregates |
2015 |
37 |
PMTCT_ARV_NGI |
Sum of Regimen disaggregates |
2015 |
38 |
PMTCT_EID |
By infants who received their first virologic HIV test between 2 and 12 months of age |
2015 |
42 |
PMTCT_EID |
By infants with a positive virologic test result within 12 months of birth |
2015 |
2 |
PMTCT_EID |
Number of HIV- positive pregnant women identified during the reporting period (include known HIV-positive women at entry into PMTCT) |
2015 |
42 |
PMTCT_EID |
Number of infants who had a virologic HIV test within 12 months of birth during the reporting period |
2015 |
33 |
PMTCT_EID |
Sum of Infant Age disaggregates |
2015 |
42 |
PMTCT_STAT |
By: Known positives at entry |
2015 |
16 |
PMTCT_STAT |
By: Number of new positives identified |
2015 |
26 |
PMTCT_STAT |
Number of new ANC and L&D clients |
2015 |
629 |
PMTCT_STAT |
Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) |
2015 |
598 |
PMTCT_STAT |
Sum of Positives Status disaggregates |
2015 |
42 |
PMTCT_STAT_NGI |
By: Known positives at entry |
2015 |
16 |
PMTCT_STAT_NGI |
By: Number of new positives identified |
2015 |
26 |
PMTCT_STAT_NGI |
Number of new ANC and L&D clients |
2015 |
629 |
PMTCT_STAT_NGI |
Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) |
2015 |
598 |
PMTCT_STAT_NGI |
Sum of Positives Status disaggregates |
2015 |
42 |
PP_PREV |
Age/sex: 10-14 Female |
2015 |
108 |
PP_PREV |
Age/sex: 10-14 Female |
2015 |
166 |
PP_PREV |
Age/sex: 10-14 Male |
2015 |
88 |
PP_PREV |
Age/sex: 10-14 Male |
2015 |
122 |
PP_PREV |
Age/sex: 15-19 Female |
2015 |
385 |
PP_PREV |
Age/sex: 15-19 Female |
2015 |
533 |
PP_PREV |
Age/sex: 15-19 Male |
2015 |
594 |
PP_PREV |
Age/sex: 15-19 Male |
2015 |
290 |
PP_PREV |
Age/sex: 20-24 Female |
2015 |
337 |
PP_PREV |
Age/sex: 20-24 Female |
2015 |
466 |
PP_PREV |
Age/sex: 20-24 Male |
2015 |
498 |
PP_PREV |
Age/sex: 20-24 Male |
2015 |
243 |
PP_PREV |
Age/sex: 25-49 Female |
2015 |
883 |
PP_PREV |
Age/sex: 25-49 Female |
2015 |
1,222 |
PP_PREV |
Age/sex: 25-49 Male |
2015 |
1,313 |
PP_PREV |
Age/sex: 25-49 Male |
2015 |
642 |
PP_PREV |
Age/sex: 50+ Female |
2015 |
28 |
PP_PREV |
Age/sex: 50+ Female |
2015 |
48 |
PP_PREV |
Age/sex: 50+ Male |
2015 |
49 |
PP_PREV |
Age/sex: 50+ Male |
2015 |
26 |
PP_PREV |
Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period |
2015 |
4,282 |
PP_PREV |
Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period |
2015 |
3,757 |
PP_PREV |
Sum of Age/Sex disaggregates |
2015 |
4,283 |
PP_PREV |
Sum of Age/Sex disaggregates |
2015 |
3,758 |
SITE_SUPP |
By program area/support type: Care and Support Direct Service Delivery (DSD) |
2015 |
4 |
SITE_SUPP |
By program area/support type: Food and Nutrition Direct Service Delivery (DSD) |
2015 |
4 |
SITE_SUPP |
By program area/support type: General Population Prevention Direct Service Delivery (DSD) |
2015 |
4 |
SITE_SUPP |
By program area/support type: HTC Direct Service Delivery (DSD) |
2015 |
4 |
SITE_SUPP |
By program area/support type: Key Populations Prevention Direct Service Delivery (DSD) |
2015 |
4 |
SITE_SUPP |
By program area/support type: Lab Direct Service Delivery (DSD) |
2015 |
4 |
SITE_SUPP |
By program area/support type: OVC Direct Service Delivery (DSD) |
2015 |
4 |
SITE_SUPP |
By program area/support type: PMTCT Direct Service Delivery (DSD) |
2015 |
4 |
SITE_SUPP |
By program area/support type: TB/HIV Direct Service Delivery (DSD) |
2015 |
4 |
SITE_SUPP |
By program area/support type: Treatment Direct Service Delivery (DSD) |
2015 |
4 |
SITE_SUPP |
Number of unique sites supported by PEPFAR |
2015 |
4 |
TB_SCREEN |
Aggregated Age - USE WITH HQ PERMISSION ONLY: <15 |
2015 |
1,035 |
TB_SCREEN |
Aggregated Age - USE WITH HQ PERMISSION ONLY: 15+ |
2015 |
6,686 |
TB_SCREEN |
Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load |
2015 |
8,322 |
TB_SCREEN |
Sex: Female |
2015 |
5,034 |
TB_SCREEN |
Sex: Male |
2015 |
2,687 |
TB_SCREEN |
Sum of Aggregated Age disaggregates |
2015 |
7,721 |
TB_SCREEN |
Sum of Sex disaggregates |
2015 |
7,721 |
TB_SCREEN |
The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period |
2015 |
7,721 |
TX_CURR |
Aggregated Age/Sex: <15 Female |
2015 |
289 |
TX_CURR |
Aggregated Age/Sex: <15 Male |
2015 |
267 |
TX_CURR |
Aggregated Age/Sex: 15+ Female |
2015 |
4,431 |
TX_CURR |
Aggregated Age/Sex: 15+ Male |
2015 |
2,241 |
TX_CURR |
Number of adults and children receiving antiretroviral therapy (ART) |
2015 |
7,228 |
TX_CURR |
Sum of Aggregated Age/Sex <15 |
2015 |
556 |
TX_CURR |
Sum of Aggregated Age/Sex 15+ |
2015 |
6,672 |
TX_CURR |
Sum of Aggregated Age/Sex disaggregates |
2015 |
7,228 |
TX_CURR_NGI |
Aggregated Age/Sex: <15 Female |
2015 |
289 |
TX_CURR_NGI |
Aggregated Age/Sex: <15 Male |
2015 |
267 |
TX_CURR_NGI |
Aggregated Age/Sex: 15+ Female |
2015 |
4,431 |
TX_CURR_NGI |
Aggregated Age/Sex: 15+ Male |
2015 |
2,241 |
TX_CURR_NGI |
Number of adults and children receiving antiretroviral therapy (ART) |
2015 |
7,228 |
TX_CURR_NGI |
Sum of Aggregated Age/Sex <15 |
2015 |
556 |
TX_CURR_NGI |
Sum of Aggregated Age/Sex 15+ |
2015 |
6,672 |
TX_CURR_NGI |
Sum of Aggregated Age/Sex disaggregates |
2015 |
7,228 |
TX_NEW |
Aggregated Grouping by Age/Sex: <15 Female |
2015 |
84 |
TX_NEW |
Aggregated Grouping by Age/Sex: <15 Male |
2015 |
73 |
TX_NEW |
Aggregated Grouping by Age/Sex: 15+ Female |
2015 |
1,437 |
TX_NEW |
Aggregated Grouping by Age/Sex: 15+ Male |
2015 |
560 |
TX_NEW |
Number of adults and children newly enrolled on antiretroviral therapy (ART) |
2015 |
2,154 |
TX_NEW |
Sum of Aggregated Age/Sex disaggregates |
2015 |
2,154 |
TX_RET |
Aggregated Age: <15 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) |
2015 |
134 |
TX_RET |
Aggregated Age: 15+ (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) |
2015 |
1,706 |
TX_RET |
Number of adults and children who are still alive and on treatment at 12 months after initiating ART |
2015 |
1,840 |
TX_RET |
Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up |
2015 |
2,023 |
TX_RET_den |
Aggregated Age: <15 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) |
2015 |
148 |
TX_RET_den |
Aggregated Age: 15+ (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) |
2015 |
1,875 |